首页> 外国专利> Auto-ligating oligonucleotide antisense compounds having diagnostic and therapeutic applications

Auto-ligating oligonucleotide antisense compounds having diagnostic and therapeutic applications

机译:自动连接具有诊断和治疗用途的寡核苷酸反义化合物

摘要

The invention provides compositions and a method for delivering an antisense compound or probe to a target polynucleotide. The compositions of the invention comprise a plurality of compounds each having an oligonucleotide moiety from about 4 to 12 monomers in length whose 3' and/or 5' termini have been modified by the addition of one or more terminal binding moieties. Whenever the oligonucleotide moieties specifically anneal to a target polynucleotide in a contiguous end-to-end fashion, the terminal binding moieties are capable of spontaneously interacting with one another to form a covalent linkages or stable complexes so that an effective antisense compound or probe is formed. The invention facilitates the delivery of antisense compounds to their targets and reduces the likelihood of nonspecific binding to non-target structures.
机译:本发明提供了将反义化合物或探针递送至靶多核苷酸的组合物和方法。本发明的组合物包含多种化合物,每个化合物具有长度为约4至12个单体的寡核苷酸部分,其3'和/或5'末端已经通过添加一个或多个末端结合部分而被修饰。每当寡核苷酸部分以连续的端对端方式与目标多核苷酸特异性退火时,末端结合部分都能够自发彼此相互作用形成共价键或稳定的复合物,从而形成有效的反义化合物或探针。本发明促进了反义化合物向其靶标的递送,并降低了非特异性结合至非靶标结构的可能性。

著录项

  • 公开/公告号AU7258194A

    专利类型

  • 公开/公告日1995-02-06

    原文格式PDF

  • 申请/专利权人 LYNX THERAPEUTICS INC.;

    申请/专利号AU19940072581

  • 发明设计人 SERGEI M GRYAZNOV;

    申请日1994-07-11

  • 分类号C07H17/00;A61K31/395;C12Q1/00;G01N33/53;

  • 国家 AU

  • 入库时间 2022-08-22 04:15:20

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号